ConductScience.org, home

Paper17202201

The North Jutland County Diabetic Retinopathy Study (NCDRS) 2. Non-ophthalmic parameters and clinically significant macular oedema.

Knudsen LL and 3 others. Br J Ophthalmol, 2007. Cited by 14 papers, by iCite.

Cite this record

ConductScience Library. The North Jutland County Diabetic Retinopathy Study (NCDRS) 2. Non-ophthalmic parameters and clinically significant macular oedema. Papers, record 17202201. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/17202201

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
The North Jutland County Diabetic Retinopathy Study (NCDRS) 2. Non-ophthalmic parameters and clinically significant macular oedema.
PubMed
Journal
Br J Ophthalmol
PubMed
Year
2007
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
14
iCite
Relative citation ratio, by iCite
0.47
iCite
Revised in PubMed
2026-01-28
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Knudsen LLL L
2Lervang HHH-H
3Lundbye-Christensen SS
4Gorst-Rasmussen AA

Source PubMed

Download CSV of authors

Topics18

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Diabetes Mellitus, Type 1Major topic
Diabetes Mellitus, Type 2Major topic
Diabetic RetinopathyMajor topic
Macular EdemaMajor topic
Adolescent
Adult
Albuminuria
Blood Pressure
Cross-Sectional Studies
Denmark
Diabetic Neuropathies
Glycated Hemoglobin
Humans
Mass Screening
Prevalence
Risk Factors
Severity of Illness Index
Time Factors

Source PubMed

Download CSV of topics

References8

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
115232600Epidemiology of diabetic retinopathy and macular oedema: a systematic review.Eye (Lond)2004https://conductscience.org/library/papers/15232600PubMed
26521986The Wisconsin epidemiologic study of diabetic retinopathy. IV. Diabetic macular edema.Ophthalmology1984https://conductscience.org/library/papers/6521986PubMed
32988264Ocular complications in insulin treated diabetes mellitus. An epidemiological study.Acta Ophthalmol Suppl (1985)1985https://conductscience.org/library/papers/2988264PubMed
416825278The North Jutland County Diabetic Retinopathy Study: population characteristics.Br J Ophthalmol2006https://conductscience.org/library/papers/16825278PubMed
52587045The Wisconsin epidemiologic study of diabetic retinopathy. XI. The incidence of macular edema.Ophthalmology1989https://conductscience.org/library/papers/2587045PubMed
68366922The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus.N Engl J Med1993https://conductscience.org/library/papers/8366922PubMed
77826293The effect of intensive diabetes treatment on the progression of diabetic retinopathy in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial.Arch Ophthalmol1995https://conductscience.org/library/papers/7826293PubMed
82866759Photocoagulation for diabetic macular edema. Early Treatment Diabetic Retinopathy Study report number 1. Early Treatment Diabetic Retinopathy Study research group.Arch Ophthalmol1985https://conductscience.org/library/papers/2866759PubMed

Download CSV of references

Cited by8

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 14 citations.

PMIDTitleJournalYearIn PapersSource
31637196Association of urinary albumin excretion with central foveal thickness and intravitreal conbercept treatment frequency in patients with diabetic macular edema.Int J Ophthalmol2019https://conductscience.org/library/papers/31637196PubMed
30679285Profile of a population-based diabetic macular oedema study: the Liverpool Eye and Diabetes Study (Sydney).BMJ Open2019https://conductscience.org/library/papers/30679285PubMed
26177037Risk Factors for Retinopathy and DME in Type 2 Diabetes-Results from the German/Austrian DPV Database.PLoS One2015https://conductscience.org/library/papers/26177037PubMed
23626903Optimal treatment of diabetic retinopathy.Ther Adv Endocrinol Metab2013https://conductscience.org/library/papers/23626903PubMed
23457327Current treatments in diabetic macular oedema: systematic review and meta-analysis.BMJ Open2013https://conductscience.org/library/papers/23457327PubMed
22937513Risk factors for clinically significant macular edema in a multi-ethnics population with type 2 diabetes.Int J Ophthalmol2012https://conductscience.org/library/papers/22937513PubMed
22356289Ranibizumab: in diabetic macular oedema.Drugs2012https://conductscience.org/library/papers/22356289PubMed
20964459Current approaches to the management of diabetic retinopathy and diabetic macular oedema.Drugs2010https://conductscience.org/library/papers/20964459PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/17202201

GET https://conductscience.org/api/papers/v1/17202201/authors